Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

SRP8051

Sigma-Aldrich

CD152 (human): FC (human) (non-lytic)

recombinant, expressed in CHO cells, ≥98% (SDS-PAGE)

Synonyme(s) :

CTLA-4, Cytotoxic T-lymphocyte-associated antigen 4, Hepatitis A virus cellular receptor 2

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
12352200
Nomenclature NACRES :
NA.32

Source biologique

human

Produit recombinant

expressed in CHO cells

Pureté

≥98% (SDS-PAGE)

Forme

lyophilized

Poids mol.

monomer 39 kDa by calculation

Conditionnement

pkg of 100 μg

Impuretés

<0.06 EU/μg endotoxin, tested

Couleur

white

Numéro d'accès UniProt

Conditions d'expédition

wet ice

Température de stockage

−20°C

Informations sur le gène

human ... CTLA4(1493)

Description générale

CD152 (CTLA-4 (cytotoxic T-lymphocyte associated protein 4)) and CD28 are structurally homologous molecules that are members of the immunoglobulin (Ig) gene superfamily. Both CD152 and CD28 are composed of a single Ig V-like extracellular domain, a transmembrane domain and an intracellular domain.
CD152 and CD28 are both expressed on the cell surface as homodimers or as monomers. CD152 was originally identified as a gene that was specifically expressed by cytotoxic T lymphocytes. However, CD152 transcripts have since been found in both Th1 and Th2, and CD4+ and CD8+ T cell clones. Whereas, CD28 expression is constitutive on the surfaces of 95% of CD4+ T cells and 50% of CD8+ T cells and is down regulated upon T cell activation, CD152 expression is upregulated rapidly following T cell activation and peaks approximately 24 hours following activation. Although both CD152 and CD28 can bind to the same ligands, CD152 binds to B71 and B72 with 20-100-fold higher affinity than CD28.

Actions biochimiques/physiologiques

CD152 (CTLA-4) and CD28, together with their ligands B7-1 and B7-2 (cluster of differentiation 80 and 86 respectively), constitute one of the dominant costimulatory pathways that regulate T and B cell responses. CTLA-4 (cytotoxic T-lymphocyte associated protein 4) is known to prevent immune responses, and its deficiency causes fatal lymphoproliferation in mouse models. Overexpression of the gene is observed in rheumatoid arthritis. Mutation in CTLA-4 is associated with insulin-dependent (type 1) diabetes mellitus, Grave′s disease and Hashimoto′s thyroiditis.

Forme physique

Lyophilized from 0.2 μm-filtered solution in PBS.

Reconstitution

Reconstitute at 100 μg/mL in sterile PBS.

Autres remarques

The extracellular domain of human CD152 [CTLA-4] (aa 37-160) is fused to the N-terminus of the Fc region of a mutant human IgG1.

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

T-cell regulation by CD28 and CTLA-4.
Alegre M L, et al.
Nature Reviews: Immunology, 1(3), 220-220 (2001)
CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.
Romo-Tena J, et al.
Autoimmunity Reviews, 12(12), 1171-1176 (2013)
Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K, et al.
Clinical and Experimental Immunology, 115(3), 451-451 (1999)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique